1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Incisional (Ventral) Hernia Global Clinical Trials Review, H2, 2015

Incisional (Ventral) Hernia Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Incisional (Ventral) Hernia Global Clinical Trials Review, H2, 2015" provides an overview of Incisional (Ventral) Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Incisional (Ventral) Hernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Incisional (Ventral) Hernia Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Europe 8
Top Countries Contributing to Clinical Trials in North America 9
Clinical Trials by G7 Countries: Proportion of Incisional (Ventral) Hernia to Genito Urinary System And Sex Hormones Clinical Trials 10
Clinical Trials by Phase in G7 Countries 11
Clinical Trials by Phase 12
Clinical Trials by Trial Status 13
Clinical Trials by End Point Status 14
Subjects Recruited Over a Period of Time 15
Clinical Trials by Sponsor Type 16
Prominent Sponsors 17
Top Companies Participating in Incisional (Ventral) Hernia Therapeutics Clinical Trials 18
Prominent Drugs 19
Clinical Trial Profile Snapshots 20
Appendix 26
Abbreviations 26
Definitions 26
Research Methodology 27
Secondary Research 27
About GlobalData 28
Contact Us 28
Disclaimer 28
Source 29

List of Tables
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials by Region, 2015* 5
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 8
Incisional (Ventral) Hernia Therapeutics Clinical Trials, North America, Top Countries, 2015* 9
Proportion of Incisional (Ventral) Hernia to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 10
Incisional (Ventral) Hernia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 11
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials by Phase, 2015* 12
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 13
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 14
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 15
Incisional (Ventral) Hernia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 16
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 17
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 18
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 19

List of Figures
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 8
Proportion of Incisional (Ventral) Hernia to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 10
Incisional (Ventral) Hernia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 11
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 12
Incisional (Ventral) Hernia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 13
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 15
Incisional (Ventral) Hernia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 16
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 17
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 18
Incisional (Ventral) Hernia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 19
GlobalData Methodology 27

Companies Mentioned
Nestle S.A.
Kimberly-Clark Corporation
Johnson and Johnson
Baxter International Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Liver Cirrhosis- Market Insights, Epidemiology and Market Forecast-2023

Liver Cirrhosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Liver Cirrhosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Peptic Ulcer  - Market Insights, Epidemiology and Market Forecast-2023

Peptic Ulcer  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Peptic Ulcer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Crohn’s disease (CD)- Market Insights, Epidemiology and Market Forecast-2023

Crohn’s disease (CD)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Crohn’s disease (CD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.